5% STAKE4598.TTSECAYMAN ISLANDS

Evo Fund lowers stake in Delta-Fly Pharma to 18.34%

Stake history

10%20%30%40%50%43.20%Aug 17Aug 17: 43.20% · S100YX1041.97%Aug 28Aug 28: 41.97% · S100YZ7033.39%Sep 8Sep 8: 33.39% · S100Z0SR32.11%Sep 9Sep 9: 32.11% · S100Z11422.71%Sep 16Sep 16: 22.71% · S100Z2FG20.65%Oct 7Oct 7: 20.65% · S100Z6NB22.55%Oct 8Oct 8: 22.55% · S100Z6RS21.47%Oct 21Oct 21: 21.47% · S100Z95T19.39%Nov 2Nov 2: 19.39% · S100ZB2G18.34%Nov 9Nov 9: 18.34% · S100ZD0M
10%20%30%40%50%43.20%Aug 17Aug 17: 43.20% · S100YX1041.97%Aug 28Aug 28: 41.97% · S100YZ7033.39%Sep 8Sep 8: 33.39% · S100Z0SR32.11%Sep 9Sep 9: 32.11% · S100Z11422.71%Sep 16Sep 16: 22.71% · S100Z2FG20.65%Oct 7Oct 7: 20.65% · S100Z6NB22.55%Oct 8Oct 8: 22.55% · S100Z6RS21.47%Oct 21Oct 21: 21.47% · S100Z95T19.39%Nov 2Nov 2: 19.39% · S100ZB2G18.34%Nov 9Nov 9: 18.34% · S100ZD0M

Summary

Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2026-11-09 11:49 JST concerning Delta-Fly Pharma, Inc. Reported holding ratio: 18.34%, previous report: 19.39%.

Open the price chart on TradingView.

Source: EDINET S100ZD0M ↗ · PDL1.0 · Not investment advice